Article
AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.
Cardiovascular drugs and therapy - 1 Apr 2014
Smolenski Ryszard T, Rybakowska Iwona, Turyn Jacek, Romaszko Paweł, Zabielska Magdalena, Taegtmeyer Anne, Słomińska Ewa M, Kaletha Krystian K, Barton Paul J R
Abstract excerpt
Nucleotide metabolism and signalling is directly linked to myocardial function. Therefore analysis how diversity of genes coding nucleotide metabolism related proteins affects clinical progress of heart disease could provide valuable information for development of new treatments. Several studies identified that polymorphism of AMP deaminase 1 gene (AMPD1), in particular the common C34T variant of this gene was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
